Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

Syn­cro­mune, a biotech start­up work­ing on com­bi­na­tion im­munother­a­pies, has put to­geth­er a $100 mil­lion Se­ries A, the com­pa­ny told End­points News.

The round was led …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER